RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
0.9000
+0.2390 (36.16%)
At close: Aug 31, 2026, 4:00 PM EDT
0.8529
-0.0471 (-5.23%)
After-hours: Aug 31, 2026, 7:59 PM EDT
RedHill Biopharma Market Cap
RedHill Biopharma has a market cap or net worth of $5.47 million as of August 31, 2026. Its market cap has increased by 221.93% in one year.
Market Cap
5.47M
Enterprise Value
2.57M
1-Year Change
221.93%
Ranking
Category
Stock Price
$0.90
ChartMarket Cap Chart
Since January 7, 2013, RedHill Biopharma's market cap has decreased from $58.80M to $5.47M, a decrease of -90.69%. That is a compound annual growth rate of -15.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 3.40M | 41.67% |
| Dec 31, 2025 | 2.40M | -69.62% |
| Dec 31, 2024 | 7.90M | 68.09% |
| Dec 29, 2023 | 4.70M | -47.78% |
| Dec 30, 2022 | 9.00M | -92.54% |
| Dec 31, 2021 | 120.70M | -57.65% |
| Dec 31, 2020 | 285.00M | 65.51% |
| Dec 31, 2019 | 172.20M | 45.81% |
| Dec 31, 2018 | 118.10M | 34.66% |
| Dec 29, 2017 | 87.70M | -34.06% |
| Dec 30, 2016 | 133.00M | 17.49% |
| Dec 31, 2015 | 113.20M | 31.93% |
| Dec 31, 2014 | 85.80M | 37.28% |
| Dec 31, 2013 | 62.50M | 6.29% |
| Jan 7, 2013 | 58.80M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sonoma Pharmaceuticals | 6.27M |
| Gelteq | 6.21M |
| InMed Pharmaceuticals | 6.16M |
| Apimeds Pharmaceuticals US | 5.84M |
| BioXcel Therapeutics | 5.68M |
| cbdMD | 5.60M |
| Sunshine Biopharma | 4.46M |
| Universe Pharmaceuticals INC | 3.19M |